Fuji Chemical Focused on Astaxanthin

July 1, 2009

Researchers at Fuji Chemical Industry (Fuji; Toyama, Japan) are researching the supplement AstaREAL astaxanthin for its potential to cure asthenopia, commonly known as eye fatigue, reports its U.S. subsidiary Fuji Health Science (Burlington, NJ).

Researchers at Fuji Chemical Industry (Fuji; Toyama, Japan) are researching the supplement AstaREAL astaxanthin for its potential to cure asthenopia, commonly known as eye fatigue, reports its U.S. subsidiary Fuji Health Science (Burlington, NJ).

Astaxanthin is a natural antioxidant that can be abundantly found in the freshwater microalgae, Haematococcus pluvialis. Fuji scientists believe it can reduce cellular inflammation and improve capillary blood flow for the lens of the eye. The company has sponsored eleven human studies with astaxanthin on patients with symptoms of asthenopia. Fuji also cultivates astaxanthin at locations in Hawaii and Sweden.

Related Content:

News